Osteal Therapeutics, Inc.

About Osteal Therapeutics, Inc.

Osteal Therapeutics is a musculoskeletal therapeutics company focused on developing medications for the treatment of orthopedic infections. Their mission is to improve outcomes for patients by providing targeted treatments that enhance mortality rates, quality of life, and cost of care, while aiming to eliminate the burden of orthopedic infections for patients, clinicians, and healthcare systems.

Products & Services

VT-X7:A treatment product focused on orthopedic infections, though specific details are not provided in the content.

Specialties

Orthopedic infection treatment Musculoskeletal therapeutics Targeted medical treatments for orthopedic surgeons

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series D T: - FT: Series D	A: 50000000 MR: - FA: $50 million FAN: 50000000	D: 2024-06-05 FD: 2024-06-05	4 investors
2	RT: Series C T: - FT: Series C	A: 23000000 MR: - FA: $23 million FAN: 23000000	D: 2023-09-21 FD: 2023-09-21	6 investors

Series D Latest

2024-06-05

$50.0M

4 investors (Pro only)

Series C 2023-09-21

$23.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Javad Parvizi

M.D.

A

Antonia Chen

M.D.

B

Bryan Springer

Scientific Advisor

B

Brian de Beaubien

Chief Medical Officer

D

David Cash

Co-Founder and Managing Director at Medvest Capital

J

Judson Cooper

Founding Principal of Prism Ventures LLC

View 19 more team members with Pro

Unlock Full Team Directory

Recent News